Last reviewed · How we verify

D086 — Competitive Intelligence Brief

D086 (D086) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Selective enzyme inhibitor. Area: Cardiovascular.

phase 3 Selective enzyme inhibitor Unknown Cardiovascular Small molecule Live · refreshed every 30 min

Target snapshot

D086 (D086) — Chong Kun Dang Pharmaceutical. D086 is a small molecule that acts as a selective inhibitor of the enzyme responsible for its mechanism.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
D086 TARGET D086 Chong Kun Dang Pharmaceutical phase 3 Selective enzyme inhibitor Unknown
SINECATECHINS SINECATECHINS marketed Polyphenols Unknown 2006-01-01
PODOFILOX PODOFILOX marketed Topical antiviral Unknown 1990-01-01
POLIDEXIDE SULFATE POLIDEXIDE SULFATE marketed Unknown Unknown 1974-01-01
SUTILAINS SUTILAINS marketed Unknown Unknown 1969-01-01
(18F)Flutemetamol 18fflutemetamol Pfizer marketed unknown unknown
Atm-Avi atm-avi Pfizer marketed antibiotic unknown

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

Sponsor landscape (Selective enzyme inhibitor class)

  1. Chong Kun Dang Pharmaceutical · 1 drug in this class
  2. Phytopharm Consulting Brazil · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). D086 — Competitive Intelligence Brief. https://druglandscape.com/ci/d086. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: